Literature DB >> 19223864

ICP0 inhibits the decrease of HSV amplicon-mediated transgene expression.

Masataka Suzuki1, Kazue Kasai, Akihiro Ohtsuki, Jakub Godlewski, Michal O Nowicki, E Antonio Chiocca, Yoshinaga Saeki.   

Abstract

The herpes simplex virus (HSV) amplicon vector produces an initial host response that limits transgene expression. In this study, we hypothesized that restoration of the HSV gene infected cell protein (ICP0) into the amplicon could circumvent this host response and thus overcome silencing of encoded transgenes. To test this, we constructed an amplicon vector that encodes the ICP0 under control of its native promoter (ICP0+ amplicon). Expression of ICP0 was transient and, at a multiplicity of infection (MOI) of 1, did not significantly alter interferon (IFN)-based responses against the vector or cell kinetics/apoptosis of infected cells. Chromatin immunoprecipitation (ChIP) PCR analysis revealed that conventional amplicon DNA became associated with histone deacetylase 1 (HDAC1) immediately after infection, whereas ICP0+ amplicon DNA remained relatively unbound by HDAC1 for at least 72 hours after infection. Mice administered systemic ICP0+ amplicon exhibited significantly greater and more sustained transgene expression in their livers than did those receiving conventional amplicon, likely due to increased transcriptional or post-transcriptional activity rather than increased copy numbers of vector DNA. These findings indicate that restoration of ICP0 expression may be employed within HSV amplicon constructs to decrease transgene silencing in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223864      PMCID: PMC2835108          DOI: 10.1038/mt.2008.306

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  45 in total

1.  Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0.

Authors:  W E Hobbs; N A DeLuca
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Components of the REST/CoREST/histone deacetylase repressor complex are disrupted, modified, and translocated in HSV-1-infected cells.

Authors:  Haidong Gu; Yu Liang; Gail Mandel; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-16       Impact factor: 11.205

3.  Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22.

Authors:  N Wu; S C Watkins; P A Schaffer; N A DeLuca
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  Inhibition of DNA repair by a herpes simplex virus vector enhances the radiosensitivity of human glioblastoma cells.

Authors:  Costas G Hadjipanayis; Neal A DeLuca
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

5.  The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27.

Authors:  L A Samaniego; N Wu; N A DeLuca
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

6.  Defective herpes simplex virus type 1 vectors harboring gag, pol, and env genes can be used to rescue defective retrovirus vectors.

Authors:  N Savard; F L Cosset; A L Epstein
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

7.  A hybrid herpesvirus infectious vector based on Epstein-Barr virus and herpes simplex virus type 1 for gene transfer into human cells in vitro and in vivo.

Authors:  S Wang; J M Vos
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

8.  Characterization of antiproliferative and cytotoxic properties of the HSV-1 immediate-early ICPo protein.

Authors:  Delphine Cuchet; René Ferrera; Patrick Lomonte; Alberto L Epstein
Journal:  J Gene Med       Date:  2005-09       Impact factor: 4.565

9.  Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production.

Authors:  Gregory T Melroe; Neal A DeLuca; David M Knipe
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Infectious delivery of the 132 kb CDKN2A/CDKN2B genomic DNA region results in correctly spliced gene expression and growth suppression in glioma cells.

Authors:  R Inoue; K A Moghaddam; M Ranasinghe; Y Saeki; E A Chiocca; R Wade-Martins
Journal:  Gene Ther       Date:  2004-08       Impact factor: 5.250

View more
  4 in total

1.  Constitutive and Inducible Innate Responses in Cells Infected by HSV-1-Derived Amplicon Vectors.

Authors:  Eliza Tsitoura; Alberto L Epstein
Journal:  Open Virol J       Date:  2010-06-18

2.  Differential type I interferon-dependent transgene silencing of helper-dependent adenoviral vs. adeno-associated viral vectors in vivo.

Authors:  Masataka Suzuki; Terry K Bertin; Geoffrey L Rogers; Racel G Cela; Irene Zolotukhin; Donna J Palmer; Philip Ng; Roland W Herzog; Brendan Lee
Journal:  Mol Ther       Date:  2013-01-15       Impact factor: 11.454

3.  MyD88-dependent silencing of transgene expression during the innate and adaptive immune response to helper-dependent adenovirus.

Authors:  Masataka Suzuki; Vincenzo Cerullo; Terry K Bertin; Racel Cela; Christian Clarke; Margaretha Guenther; Nicola Brunetti-Pierri; Brendan Lee
Journal:  Hum Gene Ther       Date:  2010-03       Impact factor: 5.695

4.  Herpes Virus Amplicon Vectors.

Authors:  Suresh de Silva; William J Bowers
Journal:  Viruses       Date:  2009-12-01       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.